nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—islet of Langerhans—type 2 diabetes mellitus	0.00594	0.171	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.00529	0.0452	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—retina—type 2 diabetes mellitus	0.00508	0.146	CbGeAlD
Gadopentetate dimeglumine—PGD—nephron tubule—type 2 diabetes mellitus	0.00478	0.137	CbGeAlD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—type 2 diabetes mellitus	0.00449	1	CrCbGaD
Gadopentetate dimeglumine—PGD—cardiovascular system—type 2 diabetes mellitus	0.0043	0.123	CbGeAlD
Gadopentetate dimeglumine—PGD—kidney—type 2 diabetes mellitus	0.0042	0.121	CbGeAlD
Gadopentetate dimeglumine—PGD—cortex of kidney—type 2 diabetes mellitus	0.00409	0.118	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.00401	0.0343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—adipose tissue—type 2 diabetes mellitus	0.00379	0.109	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC5A4—type 2 diabetes mellitus	0.00335	0.0286	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—G6PC—type 2 diabetes mellitus	0.00323	0.0276	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PPP1R3C—type 2 diabetes mellitus	0.00323	0.0276	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.00316	0.027	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.00274	0.0234	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—liver—type 2 diabetes mellitus	0.00266	0.0763	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC5A2—type 2 diabetes mellitus	0.00254	0.0217	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PCK1—type 2 diabetes mellitus	0.0023	0.0197	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—HK1—type 2 diabetes mellitus	0.00216	0.0184	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.00212	0.0181	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—GCKR—type 2 diabetes mellitus	0.00208	0.0178	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.00203	0.0174	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ALDOB—type 2 diabetes mellitus	0.002	0.0171	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.00177	0.0151	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.00175	0.0149	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A2—type 2 diabetes mellitus	0.00173	0.0148	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—GCK—type 2 diabetes mellitus	0.00165	0.0141	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.00163	0.0139	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC9A1—type 2 diabetes mellitus	0.00161	0.0138	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—AGER—type 2 diabetes mellitus	0.00157	0.0134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A1—type 2 diabetes mellitus	0.00134	0.0115	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—VPS26A—type 2 diabetes mellitus	0.0013	0.0111	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A4—type 2 diabetes mellitus	0.00129	0.011	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BHMT—type 2 diabetes mellitus	0.00109	0.0093	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGDS—type 2 diabetes mellitus	0.000951	0.00813	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AANAT—type 2 diabetes mellitus	0.000951	0.00813	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC5A4—type 2 diabetes mellitus	0.000948	0.0081	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PPP2CA—type 2 diabetes mellitus	0.000947	0.00809	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ENPP1—type 2 diabetes mellitus	0.000915	0.00782	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—G6PC—type 2 diabetes mellitus	0.000915	0.00782	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PPP1R3C—type 2 diabetes mellitus	0.000915	0.00782	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CDO1—type 2 diabetes mellitus	0.000902	0.0077	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPD2—type 2 diabetes mellitus	0.000902	0.0077	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AK1—type 2 diabetes mellitus	0.00086	0.00735	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—CALM1—type 2 diabetes mellitus	0.000849	0.00725	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000794	0.00678	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MAT1A—type 2 diabetes mellitus	0.000794	0.00678	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ACACA—type 2 diabetes mellitus	0.000778	0.00665	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—G6PC—type 2 diabetes mellitus	0.000767	0.00655	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000767	0.00655	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HBA2—type 2 diabetes mellitus	0.000767	0.00655	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ENPP1—type 2 diabetes mellitus	0.000767	0.00655	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ND1—type 2 diabetes mellitus	0.000767	0.00655	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GCGR—type 2 diabetes mellitus	0.000743	0.00634	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC5A2—type 2 diabetes mellitus	0.000718	0.00614	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYTB—type 2 diabetes mellitus	0.000701	0.00599	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—OXCT1—type 2 diabetes mellitus	0.000701	0.00599	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000683	0.00584	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.000663	0.00566	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PCK1—type 2 diabetes mellitus	0.000652	0.00557	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000652	0.00557	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—STAR—type 2 diabetes mellitus	0.000652	0.00557	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACACA—type 2 diabetes mellitus	0.000652	0.00557	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TLE4—type 2 diabetes mellitus	0.000635	0.00542	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ABCC8—type 2 diabetes mellitus	0.000625	0.00534	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CBS—type 2 diabetes mellitus	0.000625	0.00534	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HK1—type 2 diabetes mellitus	0.000611	0.00522	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—COX2—type 2 diabetes mellitus	0.000602	0.00514	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000602	0.00514	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA6—type 2 diabetes mellitus	0.000591	0.00505	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GCKR—type 2 diabetes mellitus	0.00059	0.00504	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UCP3—type 2 diabetes mellitus	0.000581	0.00496	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000581	0.00496	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UCP2—type 2 diabetes mellitus	0.000581	0.00496	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ALDOB—type 2 diabetes mellitus	0.000566	0.00483	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PCK1—type 2 diabetes mellitus	0.000546	0.00467	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SPRY2—type 2 diabetes mellitus	0.00054	0.00461	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RBP4—type 2 diabetes mellitus	0.000526	0.00449	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HK1—type 2 diabetes mellitus	0.000512	0.00437	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LPA—type 2 diabetes mellitus	0.000494	0.00422	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000494	0.00422	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GCKR—type 2 diabetes mellitus	0.000494	0.00422	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000494	0.00422	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000491	0.000582	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000491	0.000582	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SLC2A2—type 2 diabetes mellitus	0.000491	0.00419	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000489	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Pain—Gliclazide—type 2 diabetes mellitus	0.000489	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000489	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Losartan—type 2 diabetes mellitus	0.000488	0.000578	CcSEcCtD
Gadopentetate dimeglumine—Rash—Glimepiride—type 2 diabetes mellitus	0.000487	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000486	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000486	0.000576	CcSEcCtD
Gadopentetate dimeglumine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000485	0.000575	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000485	0.000575	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000485	0.000575	CcSEcCtD
Gadopentetate dimeglumine—Headache—Glimepiride—type 2 diabetes mellitus	0.000484	0.000573	CcSEcCtD
Gadopentetate dimeglumine—Cough—Irbesartan—type 2 diabetes mellitus	0.000483	0.000572	CcSEcCtD
Gadopentetate dimeglumine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000482	0.000572	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MTR—type 2 diabetes mellitus	0.000481	0.00411	CbGpPWpGaD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000479	0.000567	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Losartan—type 2 diabetes mellitus	0.000478	0.000567	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000478	0.000567	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000478	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000477	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Ramipril—type 2 diabetes mellitus	0.000476	0.000564	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Losartan—type 2 diabetes mellitus	0.000476	0.000564	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ALDOB—type 2 diabetes mellitus	0.000474	0.00405	CbGpPWpGaD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000473	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000472	0.000559	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—NAMPT—type 2 diabetes mellitus	0.000472	0.00403	CbGpPWpGaD
Gadopentetate dimeglumine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000471	0.000559	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000471	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000471	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Shock—Metformin—type 2 diabetes mellitus	0.000471	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Losartan—type 2 diabetes mellitus	0.00047	0.000557	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000469	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000469	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000469	0.000556	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—GCK—type 2 diabetes mellitus	0.000469	0.004	CbGpPWpGaD
Gadopentetate dimeglumine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000468	0.000555	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000468	0.000554	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000468	0.000554	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000467	0.000554	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Losartan—type 2 diabetes mellitus	0.000467	0.000553	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000466	0.000553	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IAPP—type 2 diabetes mellitus	0.000466	0.00398	CbGpPWpGaD
Gadopentetate dimeglumine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000465	0.000551	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000463	0.000549	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000463	0.000548	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000462	0.000548	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000461	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000461	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000459	0.000544	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000458	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000458	0.000542	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SLC9A1—type 2 diabetes mellitus	0.000457	0.00391	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000457	0.000542	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000457	0.000542	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000457	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Metformin—type 2 diabetes mellitus	0.000456	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Cough—Losartan—type 2 diabetes mellitus	0.000454	0.000539	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000454	0.000539	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000454	0.000538	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000453	0.000537	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000452	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000452	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000452	0.000535	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000451	0.000535	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000451	0.000534	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000449	0.000533	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Valsartan—type 2 diabetes mellitus	0.000449	0.000533	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000448	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000448	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Metformin—type 2 diabetes mellitus	0.000447	0.00053	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Ramipril—type 2 diabetes mellitus	0.000446	0.000529	CcSEcCtD
Gadopentetate dimeglumine—Shock—Irbesartan—type 2 diabetes mellitus	0.000444	0.000527	CcSEcCtD
Gadopentetate dimeglumine—Pain—Orlistat—type 2 diabetes mellitus	0.000444	0.000526	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Losartan—type 2 diabetes mellitus	0.000443	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000443	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000443	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000443	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Losartan—type 2 diabetes mellitus	0.000442	0.000524	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000441	0.000522	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—GLP1R—type 2 diabetes mellitus	0.00044	0.00376	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000439	0.000521	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000439	0.00052	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000439	0.00052	CcSEcCtD
Gadopentetate dimeglumine—Tension—Ramipril—type 2 diabetes mellitus	0.000438	0.000519	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000437	0.000518	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000437	0.000517	CcSEcCtD
Gadopentetate dimeglumine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000436	0.000517	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000436	0.000517	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000436	0.000517	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000434	0.000514	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00043	0.00051	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00043	0.000509	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00043	0.000509	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—HMGA1—type 2 diabetes mellitus	0.000429	0.00366	CbGpPWpGaD
Gadopentetate dimeglumine—Confusional state—Losartan—type 2 diabetes mellitus	0.000428	0.000508	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000428	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000427	0.000506	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Metformin—type 2 diabetes mellitus	0.000425	0.000504	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000425	0.000504	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000425	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000422	0.0005	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000421	0.000499	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PSMD6—type 2 diabetes mellitus	0.00042	0.00359	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SNAP25—type 2 diabetes mellitus	0.00042	0.00359	CbGpPWpGaD
Gadopentetate dimeglumine—Tremor—Ramipril—type 2 diabetes mellitus	0.000418	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Shock—Losartan—type 2 diabetes mellitus	0.000418	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000417	0.000495	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000417	0.000494	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000416	0.000493	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000415	0.000492	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000415	0.000492	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000414	0.000491	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000413	0.00049	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Metformin—type 2 diabetes mellitus	0.000413	0.000489	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000412	0.000489	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000411	0.000488	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000411	0.00351	CbGpPWpGaD
Gadopentetate dimeglumine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000411	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00041	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00041	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00041	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Ramipril—type 2 diabetes mellitus	0.00041	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Metformin—type 2 diabetes mellitus	0.000409	0.000485	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000408	0.000484	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CYBA—type 2 diabetes mellitus	0.000407	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000405	0.000481	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Losartan—type 2 diabetes mellitus	0.000405	0.00048	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000405	0.00048	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000405	0.00048	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CPT1A—type 2 diabetes mellitus	0.000403	0.00344	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MTR—type 2 diabetes mellitus	0.000403	0.00344	CbGpPWpGaD
Gadopentetate dimeglumine—Malaise—Ramipril—type 2 diabetes mellitus	0.000403	0.000477	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000403	0.000477	CcSEcCtD
Gadopentetate dimeglumine—Rash—Glyburide—type 2 diabetes mellitus	0.000402	0.000476	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000401	0.000476	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000401	0.000476	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Ramipril—type 2 diabetes mellitus	0.0004	0.000475	CcSEcCtD
Gadopentetate dimeglumine—Headache—Glyburide—type 2 diabetes mellitus	0.000399	0.000473	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Losartan—type 2 diabetes mellitus	0.000397	0.000471	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—NAMPT—type 2 diabetes mellitus	0.000395	0.00337	CbGpPWpGaD
Gadopentetate dimeglumine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000394	0.000467	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CALCA—type 2 diabetes mellitus	0.000394	0.00336	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000393	0.000465	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—HBA1—type 2 diabetes mellitus	0.000392	0.00335	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LIPC—type 2 diabetes mellitus	0.000392	0.00335	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GCK—type 2 diabetes mellitus	0.000392	0.00335	CbGpPWpGaD
Gadopentetate dimeglumine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000392	0.000465	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000391	0.000464	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000391	0.000464	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP11A1—type 2 diabetes mellitus	0.00039	0.00333	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00039	0.000462	CcSEcCtD
Gadopentetate dimeglumine—Cough—Ramipril—type 2 diabetes mellitus	0.00039	0.000462	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000389	0.000461	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000387	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000387	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000387	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000386	0.000458	CcSEcCtD
Gadopentetate dimeglumine—Pain—Irbesartan—type 2 diabetes mellitus	0.000386	0.000458	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000383	0.00327	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000383	0.000453	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000382	0.000452	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SLC2A1—type 2 diabetes mellitus	0.00038	0.00325	CbGpPWpGaD
Gadopentetate dimeglumine—Urticaria—Metformin—type 2 diabetes mellitus	0.00038	0.000451	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00038	0.000451	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Ramipril—type 2 diabetes mellitus	0.00038	0.000451	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000379	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000379	0.000449	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CETP—type 2 diabetes mellitus	0.000379	0.00323	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Glyburide—type 2 diabetes mellitus	0.000378	0.000448	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000378	0.000448	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000378	0.000448	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Losartan—type 2 diabetes mellitus	0.000378	0.000448	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000377	0.000447	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000377	0.000447	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—NOS1—type 2 diabetes mellitus	0.000375	0.0032	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000372	0.000442	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000372	0.000441	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000372	0.000441	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000372	0.000441	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—TCF7L2—type 2 diabetes mellitus	0.000371	0.00317	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000369	0.000438	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000369	0.000438	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000367	0.000435	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000367	0.000435	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Losartan—type 2 diabetes mellitus	0.000366	0.000434	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SLC2A4—type 2 diabetes mellitus	0.000364	0.00311	CbGpPWpGaD
Gadopentetate dimeglumine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000364	0.000432	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000364	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Losartan—type 2 diabetes mellitus	0.000363	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Pain—Losartan—type 2 diabetes mellitus	0.000363	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Rash—Gliclazide—type 2 diabetes mellitus	0.000361	0.000427	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00036	0.000427	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000359	0.000426	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000359	0.000425	CcSEcCtD
Gadopentetate dimeglumine—Shock—Ramipril—type 2 diabetes mellitus	0.000358	0.000425	CcSEcCtD
Gadopentetate dimeglumine—Headache—Gliclazide—type 2 diabetes mellitus	0.000358	0.000425	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000357	0.000424	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000357	0.000423	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000357	0.000423	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000356	0.000422	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000355	0.000421	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000354	0.00042	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000352	0.000418	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PSMD6—type 2 diabetes mellitus	0.000352	0.00301	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SNAP25—type 2 diabetes mellitus	0.000352	0.00301	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SREBF1—type 2 diabetes mellitus	0.000352	0.00301	CbGpPWpGaD
Gadopentetate dimeglumine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00035	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000347	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000347	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000347	0.000412	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CTGF—type 2 diabetes mellitus	0.000346	0.00295	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000343	0.000407	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Metformin—type 2 diabetes mellitus	0.000343	0.000407	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—HMGCR—type 2 diabetes mellitus	0.000342	0.00293	CbGpPWpGaD
Gadopentetate dimeglumine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00034	0.000404	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00034	0.000403	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Metformin—type 2 diabetes mellitus	0.000339	0.000401	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Losartan—type 2 diabetes mellitus	0.000338	0.0004	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000336	0.000398	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000336	0.000398	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000335	0.00286	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000334	0.000396	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000333	0.000394	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000332	0.000394	CcSEcCtD
Gadopentetate dimeglumine—Rash—Valsartan—type 2 diabetes mellitus	0.000331	0.000393	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000331	0.000392	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Orlistat—type 2 diabetes mellitus	0.00033	0.000391	CcSEcCtD
Gadopentetate dimeglumine—Headache—Valsartan—type 2 diabetes mellitus	0.000329	0.00039	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000327	0.000388	CcSEcCtD
Gadopentetate dimeglumine—Rash—Orlistat—type 2 diabetes mellitus	0.000327	0.000388	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000327	0.000388	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000327	0.000388	CcSEcCtD
Gadopentetate dimeglumine—Headache—Orlistat—type 2 diabetes mellitus	0.000325	0.000386	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000325	0.000385	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000324	0.000384	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000324	0.000384	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000322	0.00275	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000319	0.000379	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000318	0.00272	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000318	0.00272	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFBR2—type 2 diabetes mellitus	0.000317	0.00271	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000317	0.000375	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Metformin—type 2 diabetes mellitus	0.000316	0.000375	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000315	0.000373	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000314	0.000372	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000313	0.000371	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Valsartan—type 2 diabetes mellitus	0.000312	0.00037	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Ramipril—type 2 diabetes mellitus	0.000312	0.000369	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP3A4—type 2 diabetes mellitus	0.00031	0.00265	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000309	0.000366	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Orlistat—type 2 diabetes mellitus	0.000308	0.000366	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDKN2B—type 2 diabetes mellitus	0.000307	0.00262	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GCG—type 2 diabetes mellitus	0.000305	0.00261	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000305	0.00261	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Losartan—type 2 diabetes mellitus	0.000305	0.000361	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Metformin—type 2 diabetes mellitus	0.000304	0.000361	CcSEcCtD
Gadopentetate dimeglumine—Rash—Metformin—type 2 diabetes mellitus	0.000302	0.000358	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000301	0.000357	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Losartan—type 2 diabetes mellitus	0.000301	0.000356	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.0003	0.000356	CcSEcCtD
Gadopentetate dimeglumine—Headache—Metformin—type 2 diabetes mellitus	0.0003	0.000355	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—APOB—type 2 diabetes mellitus	0.0003	0.00256	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000299	0.000354	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000298	0.000353	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000291	0.000345	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000289	0.000343	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000288	0.000341	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000288	0.000341	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000287	0.00034	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—LPL—type 2 diabetes mellitus	0.000286	0.00244	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Irbesartan—type 2 diabetes mellitus	0.000285	0.000337	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000284	0.000337	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Metformin—type 2 diabetes mellitus	0.000284	0.000337	CcSEcCtD
Gadopentetate dimeglumine—Headache—Irbesartan—type 2 diabetes mellitus	0.000283	0.000335	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Losartan—type 2 diabetes mellitus	0.000281	0.000333	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ADCY5—type 2 diabetes mellitus	0.00028	0.00239	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Losartan—type 2 diabetes mellitus	0.00027	0.00032	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000268	0.000318	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PPP2CA—type 2 diabetes mellitus	0.000268	0.00229	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000268	0.000318	CcSEcCtD
Gadopentetate dimeglumine—Rash—Losartan—type 2 diabetes mellitus	0.000268	0.000318	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000268	0.000317	CcSEcCtD
Gadopentetate dimeglumine—Headache—Losartan—type 2 diabetes mellitus	0.000266	0.000316	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CCR5—type 2 diabetes mellitus	0.000263	0.00225	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GNB3—type 2 diabetes mellitus	0.000263	0.00225	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000263	0.00225	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HMOX1—type 2 diabetes mellitus	0.000262	0.00224	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000261	0.00031	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CAT—type 2 diabetes mellitus	0.000258	0.00221	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000258	0.000306	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MTHFR—type 2 diabetes mellitus	0.000257	0.0022	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Losartan—type 2 diabetes mellitus	0.000252	0.000299	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—APOB—type 2 diabetes mellitus	0.000251	0.00214	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000249	0.000296	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—HIF1A—type 2 diabetes mellitus	0.000246	0.0021	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IRS2—type 2 diabetes mellitus	0.000245	0.00209	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTM1—type 2 diabetes mellitus	0.000244	0.00208	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000241	0.000286	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CALM1—type 2 diabetes mellitus	0.000241	0.00206	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—APOE—type 2 diabetes mellitus	0.00024	0.00205	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LPL—type 2 diabetes mellitus	0.00024	0.00205	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—APOA1—type 2 diabetes mellitus	0.000237	0.00202	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ADCY5—type 2 diabetes mellitus	0.000234	0.002	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPX1—type 2 diabetes mellitus	0.000234	0.002	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000232	0.000275	CcSEcCtD
Gadopentetate dimeglumine—Rash—Ramipril—type 2 diabetes mellitus	0.00023	0.000272	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00023	0.000272	CcSEcCtD
Gadopentetate dimeglumine—Headache—Ramipril—type 2 diabetes mellitus	0.000228	0.000271	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CD36—type 2 diabetes mellitus	0.000228	0.00194	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000225	0.00192	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOS2—type 2 diabetes mellitus	0.000223	0.00191	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Ramipril—type 2 diabetes mellitus	0.000216	0.000257	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—MTHFR—type 2 diabetes mellitus	0.000216	0.00184	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IRS1—type 2 diabetes mellitus	0.000214	0.00183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPARA—type 2 diabetes mellitus	0.000212	0.00181	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AGT—type 2 diabetes mellitus	0.000205	0.00175	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—INS—type 2 diabetes mellitus	0.000205	0.00175	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CALM1—type 2 diabetes mellitus	0.000201	0.00172	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—APOE—type 2 diabetes mellitus	0.000201	0.00172	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—APOA1—type 2 diabetes mellitus	0.000198	0.0017	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT2—type 2 diabetes mellitus	0.000198	0.00169	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SERPINE1—type 2 diabetes mellitus	0.000188	0.00161	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PIK3R1—type 2 diabetes mellitus	0.00018	0.00153	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOS3—type 2 diabetes mellitus	0.00018	0.00153	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPARG—type 2 diabetes mellitus	0.000175	0.00149	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—INS—type 2 diabetes mellitus	0.000172	0.00147	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—type 2 diabetes mellitus	0.000164	0.0014	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALB—type 2 diabetes mellitus	0.000157	0.00134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3R1—type 2 diabetes mellitus	0.00015	0.00128	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NOS3—type 2 diabetes mellitus	0.00015	0.00128	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—type 2 diabetes mellitus	0.000138	0.00118	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SRC—type 2 diabetes mellitus	0.000133	0.00113	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFB1—type 2 diabetes mellitus	0.000119	0.00101	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EGFR—type 2 diabetes mellitus	0.000116	0.000995	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IL6—type 2 diabetes mellitus	8.95e-05	0.000764	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT1—type 2 diabetes mellitus	8.26e-05	0.000705	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKT1—type 2 diabetes mellitus	6.91e-05	0.000591	CbGpPWpGaD
